NF2 BIOSOLUTIONS SEEKING A CURE OR PREVENTATIVE TREATMENT FOR NF2 BY VIGOROUSLY SUPPORTING AND ADVANCING EXISTING AND NEXT GENERATION BIOMEDICAL TECHNOLOGIES SUCH AS GENE TRANSFER THERAPY AND IMMUNONTHERAPY
Annual Revenue
$226,008
Known Funders
14
Grants Received
22
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $226,008 | $316,809 | $621,589 |
| 2023 | $772,336 | $966,416 | $712,390 |
| 2022 | $418,620 | $308,337 | $906,470 |
| 2021 | $544,244 | $386,234 | $796,187 |
| 2020 | $708,384 | $537,191 | $638,177 |
Top Funders
NEW ALBANY, IN
Washington, DC
Washington, DC
SOUTHEASTERN, PA
SOUTHEASTERN, PA
MIAMI, FL
Washington, DC
ALEXANDRIA, VA
Wilmington, DE
Wilmington, DE
Showing top 10 of 14 funders.
Key Personnel
From 2024 IRS 990 filing
CLAUDIA SCHMIDT
DIRECTOR
JILL VELEZ
SECRETARY
MARY SELL
DIRECTOR
DEIAN OWEN
TREASURER
AMY WILLIAMS
DIRECTOR
CHRIS SERLE
DIRECTOR
VITO GRASSO
DIRECTOR
GILLES ATLAN
VICE PRESIDENT
NICOLE HENWOOD
PRESIDENT
Frequently Asked Questions
Other Nonprofits in Pennsylvania
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.